sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
19-Dec-2014 15:17
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 551-575 out of 943.

<< < 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 > >>

Public Release: 18-Nov-2013
Nature Communications
Bacteria use lethal cytotoxins to evade antibiotic treatment
Bacteria that cause infectious diseases produce a number of cytotoxins, and an international research team has now found the mechanism behind one of these toxins. The new results could make it possible in future to develop new treatment methods to impair the cytotoxic activity and thereby reduce the severity of infectious diseases.

Contact: Ditlev E. Brodersen
deb@mb.au.dk
45-21-66-90-01
Aarhus University

Public Release: 17-Nov-2013
Journal of Virology
Researchers capture structure of key part of deadly Nipah virus
Researchers at The Scripps Research Institute have solved the structure of a key protein in the Nipah virus, which could pave the way for the development of a much-needed antiviral drug.
National Institutes of Health, Achievement Rewards for College Scientists, Burroughs Welcome Fund

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute

Public Release: 15-Nov-2013
American Society of Tropical Medicine and Hygiene 62nd Annual Meeting
PLOS Neglected Tropical Diseases
Vivax malaria may be evolving around natural defense
Researchers at Case Western Reserve University and Cleveland Clinic Lerner Research Institute have discovered recent genetic mutations in a parasite that causes over 100 million cases of malaria annually -- changes that may render tens of millions of Africans who had been considered resistant, susceptible to infection.
The Clinical and Translational Science Collaborative of Cleveland, NIH/National Institute of Allergy and Infectious Diseases

Contact: Kevin Mayhood
kevin.mayhood@case.edu
216-368-4442
Case Western Reserve University

Public Release: 15-Nov-2013
American Society of Tropical Medicine and Hygiene 62nd Annual Meeting
PLOS Neglected Tropical Diseases
New research finds potential risk for millions in Africa believed resistant to vivax malaria
Provocative new research shows that the Plasmodium vivax parasite, responsible for nearly 20 million cases of malaria in 2010, may be "rapidly evolving" to overcome the natural resistance conferred by a blood type found in millions of Africans, scientists reported today at the annual meeting of the American Society of Tropical Medicine and Hygiene.

Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722
American Society of Tropical Medicine and Hygiene

Public Release: 15-Nov-2013
American Society of Tropical Medicine and Hygiene 62nd Annual Meeting
Scientists report human dietary supplement cures lab animals infected with human intestinal parasite
Laboratory animals fed a modified version of a common human dietary supplement were completely cured of intestinal worms that belong to a family of parasites that currently infect 1.5 billion people, or almost one quarter of the world's population, according to new research presented today at the annual meeting of the American Society of Tropical Medicine and Hygiene.

Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722
Burness Communications

Public Release: 14-Nov-2013
Prize will expand use of life-saving neonatal device in Africa
A low-cost device that Rice University bioengineering students invented to help premature babies breathe more easily will be rolled out to teaching hospitals in three African nations, thanks to a $400,000 award from pharmaceutical giant GlaxoSmithKline (GSK) and London-based charity Save the Children. The technology, which is known as "bubble CPAP," earned the top prize in GSK and Save the Children's inaugural Healthcare Innovation Award program.
Save the Children, GlaxoSmithKline

Contact: Jade Boyd
jadeboyd@rice.edu
713-348-6778
Rice University

Public Release: 14-Nov-2013
Cell, Host & Microbe
Bleeding symptom leads scientists to intracellular trafficker's role in virus propagation
Vermont researchers find a new important clue to how deadly rodent-borne viruses harness ERGIC-53 to ensure their reproductive success.
National Institutes of Health

Contact: Jennifer Nachbur
jennifer.nachbur@uvm.edu
802-656-7875
University of Vermont

Public Release: 14-Nov-2013
Lancet Infectious Diseases
Low-dose treatment may block malaria transmission
Lower doses of the antimalarial drug primaquine are as effective as higher doses in reducing malaria transmission, according to a study published today in Lancet Infectious Diseases by London School of Hygiene & Tropical Medicine researchers.
Wellcome Trust, Bill & Melinda Gates Foundation

Contact: Katie Steels
press@lshtm.ac.uk
44-020-792-92802
London School of Hygiene & Tropical Medicine

Public Release: 14-Nov-2013
American Society of Tropical Medicine and Hygiene 62nd Annual Meeting
Drug trial for top parasitic killer of the Americas: Mixed results, new evidence to improve therapy
According to results of the first-ever Phase 2 clinical trial in Bolivia, the drug candidate E1224 showed good safety and was effective at clearing the parasite causing Chagas disease, but had little to no sustained efficacy one year after treatment. On the other hand, standard therapy, benznidazole, was effective long term but continued to be associated with side effects. The results point to alternative dosing regimens and possible combination therapies to improve patient care.
Wellcome Trust

Contact: Oliver Yun
oyun@dndi.org
646-266-5216
Drugs for Neglected Diseases Initiative

Public Release: 14-Nov-2013
American Society of Tropical Medicine and Hygiene 62nd Annual Meeting
The Lancet
New malaria vaccines roadmap targets next generation products by 2030
The world should aim to have vaccines which reduce malaria cases by 75 percent, and are capable of eliminating malaria, licensed by 2030, according to the updated 2013 Malaria Vaccine Technology Roadmap, launched today. This new target comes in addition to the original 2006 Roadmap's goal of having a licensed vaccine against Plasmodium falciparum malaria, the most deadly form of the disease, for children under 5 years of age in sub-Saharan Africa by 2015.

Contact: Dr. Vasee Moorthy
moorthyv@who.int
41-795-406-919
WHO

Public Release: 14-Nov-2013
American Society of Tropical Medicine and Hygiene 62nd Annual Meeting
New research reveals dengue fever mystery in 2 US cities both exposed to risk
As dengue fever continues to spread from Key West north into the Florida mainland, it remains a mystery as to why this dangerous mosquito-borne illness is not yet common around Tucson, Arizona -- even though outbreaks routinely occur in nearby Mexico and mosquitoes that can carry dengue are now common in the state, according to a new research presented today at the annual meeting of the American Society of Tropical Medicine and Hygiene.

Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722
Burness Communications

Public Release: 14-Nov-2013
2013 AAPS Annual Meeting and Exposition
Novel microbicide gel for vagina and rectum shows potential for HIV prevention
Researchers developed a first-of-its-kind microbicide gel formulation that shows promise for safe vaginal and rectal administration to prevent the sexual transmission of human immunodeficiency virus. This research is being presented at the 2013 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Antonio, Nov. 10-14.

Contact: Dana Korsen
aaps@ecius.net
301-744-9636
American Association of Pharmaceutical Scientists

Public Release: 12-Nov-2013
Dr. Robert Gallo named first Homer & Martha Gudelsky Distinguished Professor in Medicine
Robert C. Gallo, M.D., has been named the first Homer & Martha Gudelsky Distinguished Professor in Medicine at the University of Maryland School of Medicine during a ceremony November 7. The ceremony also honored the Gudelsky Family Foundation for their extraordinary generosity in supporting the Institute of Human Virology at the University of Maryland School of Medicine in Baltimore, MD.

Contact: Nora Grannell
ngrannell@ihv.umaryland.edu
410-706-1954
University of Maryland Medical Center

Public Release: 12-Nov-2013
Fifth Annual World Pneumonia Day marks successes and challenges in tackling #1 killer of children
Global health advocates today commemorated the fifth annual World Pneumonia Day by calling on global leaders to scale up existing interventions and invest in new diagnostics and treatments to defeat pneumonia. Each year, pneumonia kills more children than AIDS, malaria and tuberculosis combined. A new report issued today found gradual increases in access to vaccines, treatment, and other interventions in the 15 countries with the highest numbers of child deaths from pneumonia and diarrhea.

Contact: Julie Younkin
jbuss@jhsph.edu
410-340-9784
International Vaccine Access Center

Public Release: 12-Nov-2013
2013 AAPS Annual Meeting and Exposition
CONRAD presents new technology combining contraception, HIV and herpes simplex virus-2 prevention
CONRAD Head of drug delivery, Meredith Clark, Ph.D., today presented preclinical data on a new intravaginal ring that provides contraception as well as HIV-1 and HSV-2 prevention at the 2013 American Association of Pharmaceutical Scientists Annual Meeting and Exposition in San Antonio, Texas.CONRAD's deputy director of clinical research, Marianne Callahan, will also present information on MPTs at the International Conference on Family Planning in Addis Ababa, Ethiopia.
US Agency for International Development

Contact: Annette Larkin
alarkin@conrad.org
703-772-6427
CONRAD

Public Release: 11-Nov-2013
Canadian Medical Association Journal
Some 'healthy' vegetable oils may actually increase risk of heart disease
Some vegetable oils that claim to be healthy may actually increase the risk of heart disease, and Health Canada should reconsider cholesterol-lowering claims on food labelling, states an analysis in CMAJ (Canadian Medical Association Journal): Replacing saturated animal fats with polyunsaturated vegetable oils has become common practice because they can reduce serum cholesterol levels and help prevent heart disease.

Contact: Michael Kennedy
m.kennedy@utoronto.ca
416-946-5025
University of Toronto

Public Release: 10-Nov-2013
Nature Chemical Biology
How zinc starves lethal bacteria to stop infection
Australian researchers have found that zinc can 'starve' one of the world's most deadly bacteria by preventing its uptake of an essential metal.

Contact: Dr Christopher McDevitt
christopher.mcdevitt@adelaide.edu.au
61-449-823-946
University of Adelaide

Public Release: 10-Nov-2013
Griffith joins the fight against pneumonia
Advancing the fight against pneumonia is the focus of a new online scholarly journal launched by Griffith University ePress.
Griffith University ePress

Contact: Louise Durack
l.durack@griffith.edu.au
041-964-9516
Griffith University

Public Release: 8-Nov-2013
SSI and Aeras announce initiation of Phase I/IIa clinical trial for TB vaccine candidate
Statens Serum Institut and Aeras announce the initiation of a Phase I/IIa clinical trial in South Africa for a candidate tuberculosis (TB) vaccine designed to protect people, especially those latently infected with TB, from developing active TB disease.

Contact: Annmarie Leadman
aleadman@aeras.org
240-599-3018
Aeras

Public Release: 7-Nov-2013
Biochemical Journal
Blocking the active site of thiolase
Scientists at the University of Oulu, Finland, and at the HZB break new ground for drug discovery research in the fight against sleeping sickness Scientists at the University of Oulu, Finland, and at the Helmholtz Center Berlin have shown the way to new directions in drug development against African sleeping sickness and other tropical parasitic infections.

Contact: Dr. Manfred Weiss
manfred.weiss@helmholtz-berlin.de
49-308-062-13149
Helmholtz-Zentrum Berlin für Materialien und Energie

Public Release: 7-Nov-2013
Japanese fund to invest in promising technology against malaria, tuberculosis and Chagas disease
The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.

Contact: Katy Lenard
klenard@burnesscommunications.com
301-280-5719
GHIT Fund -- Global Health Innovative Technology Fund

Public Release: 7-Nov-2013
PLOS Neglected Tropical Diseases
Climate may play a role in the distribution and prevalence of trachoma
High temperatures and low rainfall are important factors which influence the occurrence and severity of the active stages of trachoma -- the most common cause of infectious blindness -- according to a new study publishing Nov. 7, 2013, in PLOS Neglected Tropical Diseases.

Contact: Katie Steels
Katie.Steels@lshtm.ac.uk
44-207-927-2802
PLOS

Public Release: 5-Nov-2013
PLOS Medicine
Syphilis screening and treatment in pregnancy may be cost-effective in sub-Saharan Africa
Screening and treating pregnant women in sub Saharan Africa for syphilis may be a cost-effective use of resources, according to a study published in this week's PLOS Medicine. The study by Mohammed Lamorde and colleagues, suggests that screening pregnant women for syphilis usingimmunochromatographic strip point-of-care tests, and subsequent treatment with benzathine penicillin, could efficiently reduce the burden of congenital syphilis.

Contact: Fiona Godwin
medicinepress@plos.org
PLOS

Public Release: 4-Nov-2013
Population Council awarded flagship family planning implementation science project by USAID
The Population Council has been granted a cooperative agreement from the US Agency for International Development's Office of Population and Reproductive Health. The award supports the project "Strengthening Family Planning/Reproductive Health Programming through Implementation Science (EVIDENCE)," which will generate and synthesize evidence to strengthen and contribute to the scale-up of high-quality family planning and reproductive health services in USAID priority countries.
US Agency for International Development

Contact: Sasha Gruber
sgruber@popcouncil.org
Population Council

Public Release: 4-Nov-2013
Environmental Science & Technology
Virginia Tech researchers explore natural way to displace harmful germs from household plumbing
Microbes in tap water are mostly harmless, with a few exceptions. A Virginia Tech research team is investigating four harmful pathogens that have been documented in tap water and suggest a natural, probiotic way to deal with dangerous germs.

Contact: John Pastor
jdpastor@vt.edu
540-231-5646
Virginia Tech

Showing releases 551-575 out of 943.

<< < 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 > >>